FULGENT GENETICS, INC. Financing Cash Flow
FULGENT GENETICS, INC. (FLGT) reported Financing Cash Flow of -$69.06 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-07-30
- FULGENT GENETICS, INC. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was -$24.23M.
- FULGENT GENETICS, INC. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$44.83M.
- FULGENT GENETICS, INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was -$534.00K.
- FULGENT GENETICS, INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was -$445.00K.
- FULGENT GENETICS, INC. net cash provided by (used in) financing activities for fiscal 2025 was -$14.79M.
- FULGENT GENETICS, INC. net cash provided by (used in) financing activities for fiscal 2024 was -$4.85M.
- FULGENT GENETICS, INC. net cash provided by (used in) financing activities for fiscal 2023 was -$47.78M.
- FULGENT GENETICS, INC. net cash provided by (used in) financing activities for fiscal 2022 was -$77.14M, a 190.32% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$24.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | -$69.06M 10-Q · filed 2026-07-30 | -$69.59M derived: sum of 3 quarters · filed 2026-07-30 | -$70.04M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | -$44.83M 10-Q · filed 2026-05-01 | -$45.37M derived: sum of 2 quarters · filed 2026-05-01 | -$45.81M derived: sum of 3 quarters · filed 2026-05-01 | -$48.45M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | -$534.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$979.00K derived: sum of 2 quarters · filed 2026-02-27 | -$3.62M derived: sum of 3 quarters · filed 2026-07-30 | -$14.79M 10-K · filed 2026-02-27 |
| 2025-09-30 | -$445.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$3.08M derived: sum of 2 quarters · filed 2026-07-30 | -$14.26M 10-Q · filed 2025-11-07 | -$14.58M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | -$2.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | -$13.81M 10-Q · filed 2026-07-30 | -$14.14M derived: sum of 3 quarters · filed 2026-07-30 | -$14.70M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | -$11.17M 10-Q · filed 2026-05-01 | -$11.50M derived: sum of 2 quarters · filed 2026-05-01 | -$12.07M derived: sum of 3 quarters · filed 2026-05-01 | -$13.21M derived: sum of 4 quarters · filed 2026-05-01 |
| 2024-12-31 | -$327.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$894.00K derived: sum of 2 quarters · filed 2026-02-27 | -$2.04M derived: sum of 3 quarters · filed 2026-02-27 | -$4.85M 10-K · filed 2026-02-27 |
| 2024-09-30 | -$567.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$1.71M derived: sum of 2 quarters · filed 2025-11-07 | -$4.52M 10-Q · filed 2025-11-07 | -$30.47M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | -$1.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | -$3.95M 10-Q · filed 2025-08-01 | -$29.90M derived: sum of 3 quarters · filed 2026-02-27 | -$34.38M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | -$2.81M 10-Q · filed 2025-05-02 | -$28.76M derived: sum of 2 quarters · filed 2026-02-27 | -$33.23M derived: sum of 3 quarters · filed 2026-02-27 | -$49.49M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | -$25.95M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$30.43M derived: sum of 2 quarters · filed 2026-02-27 | -$46.68M derived: sum of 3 quarters · filed 2026-02-27 | -$47.78M 10-K · filed 2026-02-27 |
| 2023-09-30 | -$4.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | -$20.73M derived: sum of 2 quarters · filed 2024-11-08 | -$21.83M 10-Q · filed 2024-11-08 | -$51.43M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | -$16.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | -$17.36M 10-Q · filed 2024-08-02 | -$46.95M derived: sum of 3 quarters · filed 2025-02-28 | -$82.42M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | -$1.10M 10-Q · filed 2024-05-03 | -$30.69M derived: sum of 2 quarters · filed 2025-02-28 | -$66.16M derived: sum of 3 quarters · filed 2025-02-28 | -$77.31M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | -$29.59M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$65.06M derived: sum of 2 quarters · filed 2025-02-28 | -$76.21M derived: sum of 3 quarters · filed 2025-02-28 | -$77.14M 10-K · filed 2025-02-28 |
| 2022-09-30 | -$35.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | -$46.61M derived: sum of 2 quarters · filed 2023-11-03 | -$47.55M 10-Q · filed 2023-11-03 | -$34.39M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | -$11.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | -$12.09M 10-Q · filed 2023-08-04 | $1.07M derived: sum of 3 quarters · filed 2024-02-28 | -$1.92M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | -$934.00K 10-Q · filed 2023-05-05 | $12.22M derived: sum of 2 quarters · filed 2024-02-28 | $9.23M derived: sum of 3 quarters · filed 2024-02-28 | $37.12M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $13.15M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $10.16M derived: sum of 2 quarters · filed 2024-02-28 | $38.06M derived: sum of 3 quarters · filed 2024-02-28 | $85.41M 10-K · filed 2024-02-28 |
| 2021-09-30 | -$2.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $24.90M derived: sum of 2 quarters · filed 2022-11-07 | $72.25M 10-Q · filed 2022-11-07 | $291.15M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $27.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $75.24M 10-Q · filed 2022-08-04 | $294.14M derived: sum of 3 quarters · filed 2023-02-28 | $336.71M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $47.35M 10-Q · filed 2022-05-05 | $266.25M derived: sum of 2 quarters · filed 2023-02-28 | $308.82M derived: sum of 3 quarters · filed 2023-02-28 | $308.76M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $218.90M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $261.47M derived: sum of 2 quarters · filed 2023-02-28 | $261.42M derived: sum of 3 quarters · filed 2023-02-28 | $261.25M 10-K · filed 2023-02-28 |
| 2020-09-30 | $42.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $42.51M derived: sum of 2 quarters · filed 2021-11-09 | $42.35M 10-Q · filed 2021-11-09 | $69.99M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | -$59.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | -$223.00K 10-Q · filed 2021-08-10 | $27.42M derived: sum of 3 quarters · filed 2022-02-28 | $28.54M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | -$164.00K 10-Q · filed 2021-05-07 | $27.48M derived: sum of 2 quarters · filed 2022-02-28 | $28.60M derived: sum of 3 quarters · filed 2022-02-28 | $28.61M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $27.64M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $28.77M derived: sum of 2 quarters · filed 2022-02-28 | $28.77M derived: sum of 3 quarters · filed 2022-02-28 | $28.77M 10-K · filed 2022-02-28 |
| 2019-09-30 | $1.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $1.13M derived: sum of 2 quarters · filed 2020-11-09 | $1.14M 10-Q · filed 2020-11-09 | $1.14M derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | $5.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $9.00K 10-Q · filed 2020-08-05 | $14.00K derived: sum of 3 quarters · filed 2020-08-05 | $15.00K derived: sum of 4 quarters · filed 2020-08-05 |
| 2019-03-31 | $4.00K 10-Q · filed 2020-05-06 | $9.00K derived: sum of 2 quarters · filed 2020-05-06 | $10.00K derived: sum of 3 quarters · filed 2020-05-06 | $17.00K derived: sum of 4 quarters · filed 2020-05-06 |
| 2018-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $6.00K derived: sum of 2 quarters · filed 2020-03-13 | $13.00K derived: sum of 3 quarters · filed 2020-03-13 | $15.00K 10-K · filed 2020-03-13 |
| 2018-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $8.00K derived: sum of 2 quarters · filed 2019-11-08 | $10.00K 10-Q · filed 2019-11-08 | $14.00K derived: sum of 4 quarters · filed 2019-11-08 |
| 2018-06-30 | $7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | $9.00K 10-Q · filed 2019-08-12 | $13.00K derived: sum of 3 quarters · filed 2019-08-12 | $17.00K derived: sum of 4 quarters · filed 2019-08-12 |
| 2018-03-31 | $2.00K 10-Q · filed 2019-05-10 | $6.00K derived: sum of 2 quarters · filed 2019-05-10 | $10.00K derived: sum of 3 quarters · filed 2019-05-10 | $33.00K derived: sum of 4 quarters · filed 2019-05-10 |
| 2017-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | $8.00K derived: sum of 2 quarters · filed 2019-03-22 | $31.00K derived: sum of 3 quarters · filed 2019-03-22 | -$770.00K 10-K · filed 2019-03-22 |
| 2017-09-30 | $4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $27.00K derived: sum of 2 quarters · filed 2018-11-09 | -$774.00K 10-Q · filed 2018-11-09 | $37.08M derived: sum of 4 quarters · filed 2018-11-09 |
| 2017-06-30 | $23.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | -$778.00K 10-Q · filed 2018-08-13 | $37.08M derived: sum of 3 quarters · filed 2018-08-13 | $31.24M derived: sum of 4 quarters · filed 2018-08-13 |
| 2017-03-31 | -$801.00K 10-Q · filed 2018-05-14 | $37.05M derived: sum of 2 quarters · filed 2018-05-14 | $31.22M derived: sum of 3 quarters · filed 2018-05-14 | |
| 2016-12-31 | $37.85M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-20 | $32.02M derived: sum of 2 quarters · filed 2018-03-20 | $45.79M 10-K · filed 2018-03-20 | |
| 2016-09-30 | -$5.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | $7.93M 10-Q · filed 2017-11-13 | ||
| 2016-06-30 | $13.77M 10-Q · filed 2017-08-14 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-17 | $3.50M 10-K · filed 2017-03-17 | ||
| 2015-09-30 | $3.50M 10-Q · filed 2016-11-14 | |||
| 2014-12-31 | $4.00M 10-K · filed 2017-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |